| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.777 | 0.004 | 0.777 | 5 Hydroxytryptamine release inhibitor | 0.397 0.08 DBMET01451 | ||
| 0.754 | 0.004 | 0.754 | Histamine release inhibitor | 0.48 0.036 DBMET01451 | ||
| 0.758 | 0.017 | 0.758 | Caspase 9 stimulant | 0.505 0.058 DBMET01451 | ||
| 0.719 | 0.007 | 0.719 | Aldehyde oxidase inhibitor | 0.719 0.007 DBMET01451 | ||
| 0.68 | 0.009 | 0.68 | Cholesterol antagonist | 0.584 0.021 DBMET01451 | ||
| 0.635 | 0.004 | 0.635 | Interleukin agonist | 0.281 0.058 DBMET01451 | ||
| 0.658 | 0.038 | 0.658 | Apoptosis agonist | 0.62 0.045 DBMET01451 | ||
| 0.601 | 0.031 | 0.601 | Transcription factor NF kappa B inhibitor | 0.457 0.051 DBMET01451 | ||
| 0.563 | 0.003 | 0.563 | Alcohol oxidase inhibitor | 0.215 0.006 DBMET01451 | ||
| 0.559 | 0.002 | 0.559 | Keratolytic | 0.272 0.004 DBMET01451 | ||
| 0.567 | 0.012 | 0.567 | Lipoxygenase inhibitor | 0.287 0.078 DBMET01451 | ||
| 0.538 | 0.031 | 0.632 | Antibacterial | 0.632 0.015 DBMET01451 | DBMET01451 | |
| 0.513 | 0.019 | 0.513 | Caspase 3 stimulant | 0.334 0.064 DBMET01451 | ||
| 0.518 | 0.025 | 0.518 | Vasodilator, peripheral | |||
| 0.517 | 0.027 | 0.517 | Antithrombotic | 0.28 0.103 DBMET01451 | ||
| 0.481 | 0.005 | 0.481 | Aldehyde dehydrogenase inhibitor | 0.25 0.018 DBMET01451 | ||
| 0.545 | 0.07 | 0.545 | Antiinflammatory | 0.269 0.247 DBMET01451 | ||
| 0.474 | 0.004 | 0.474 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.382 0.009 DBMET01451 | ||
| 0.47 | 0.004 | 0.638 | Cystathionine beta-synthase inhibitor | 0.638 0.003 DBMET01451 | DBMET01451 | |
| 0.47 | 0.009 | 0.47 | Monophenol monooxygenase inhibitor | 0.451 0.009 DBMET01451 | ||
| 0.467 | 0.009 | 0.467 | Transcription factor STAT3 inhibitor | 0.244 0.088 DBMET01451 | ||
| 0.482 | 0.031 | 0.482 | GABA C receptor rho-3 antagonist | 0.426 0.051 DBMET01451 | ||
| 0.458 | 0.008 | 0.512 | Topoisomerase II inhibitor | 0.512 0.006 DBMET01451 | DBMET01451 | |
| 0.456 | 0.011 | 0.456 | Transcription factor STAT inhibitor | 0.209 0.125 DBMET01451 | ||
| 0.434 | 0.004 | 0.434 | Xanthine oxidase inhibitor | 0.237 0.014 DBMET01451 | ||
| 0.433 | 0.007 | 0.433 | Alpha-N-acetylglucosaminidase inhibitor | 0.293 0.017 DBMET01451 | ||
| 0.42 | 0.011 | 0.42 | Non-steroidal antiinflammatory agent | 0.187 0.082 DBMET01451 | ||
| 0.406 | 0.016 | 0.406 | Cyclic AMP phosphodiesterase inhibitor | 0.169 0.124 DBMET01451 | ||
| 0.412 | 0.027 | 0.412 | Free radical scavenger | 0.359 0.037 DBMET01451 | ||
| 0.416 | 0.035 | 0.416 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.215 0.091 DBMET01451 | ||
| 0.401 | 0.021 | 0.401 | DNA synthesis inhibitor | 0.387 0.023 DBMET01451 | ||
| 0.409 | 0.032 | 0.409 | Vasodilator, coronary | 0.207 0.176 DBMET01451 | ||
| 0.391 | 0.015 | 0.391 | Dual specificity phosphatase inhibitor | 0.286 0.031 DBMET01451 | ||
| 0.391 | 0.016 | 0.433 | 5 Hydroxytryptamine uptake stimulant | 0.433 0.009 DBMET01451 | DBMET01451 | |
| 0.392 | 0.017 | 0.392 | P-glycoprotein inhibitor | 0.164 0.096 DBMET01451 | ||
| 0.402 | 0.029 | 0.402 | Hypoxia-inducible factor 1 alpha inhibitor | 0.352 0.044 DBMET01451 | ||
| 0.426 | 0.054 | 0.426 | Immunosuppressant | |||
| 0.384 | 0.013 | 0.384 | Melanin inhibitor | 0.292 0.023 DBMET01451 | ||
| 0.386 | 0.02 | 0.386 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 DBMET01451 | ||
| 0.376 | 0.01 | 0.376 | Protein kinase stimulant | 0.25 0.026 DBMET01451 | ||
| 0.4 | 0.035 | 0.41 | Antioxidant | 0.41 0.033 DBMET01451 | DBMET01451 | |
| 0.399 | 0.039 | 0.399 | Apoptosis antagonist | |||
| 0.389 | 0.029 | 0.389 | Calcium channel activator | 0.33 0.064 DBMET01451 | ||
| 0.389 | 0.029 | 0.389 | Superoxide dismutase inhibitor | 0.326 0.042 DBMET01451 | ||
| 0.424 | 0.064 | 0.424 | 15-Lipoxygenase inhibitor | 0.285 0.141 DBMET01451 | ||
| 0.364 | 0.005 | 0.364 | Mediator release inhibitor | |||
| 0.384 | 0.03 | 0.384 | Hypoglycemic | 0.345 0.039 DBMET01451 | ||
| 0.384 | 0.032 | 0.384 | DNA damaging | 0.177 0.137 DBMET01451 | ||
| 0.375 | 0.026 | 0.375 | Sodium/bile acid cotransporter inhibitor | 0.349 0.04 DBMET01451 | ||
| 0.353 | 0.006 | 0.353 | Hexokinase inhibitor | 0.23 0.022 DBMET01451 | ||
| 0.348 | 0.004 | 0.348 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.243 0.006 DBMET01451 | ||
| 0.346 | 0.005 | 0.346 | Cyclooxygenase 3 inhibitor | 0.171 0.033 DBMET01451 | ||
| 0.349 | 0.017 | 0.349 | DNA methylase inhibitor | 0.165 0.105 DBMET01451 | ||
| 0.336 | 0.005 | 0.336 | Alcohol dehydrogenase inhibitor | 0.133 0.027 DBMET01451 | ||
| 0.413 | 0.089 | 0.413 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.305 0.206 DBMET01451 | ||
| 0.339 | 0.016 | 0.339 | DNA methyltransferase I inhibitor | 0.187 0.076 DBMET01451 | ||
| 0.371 | 0.049 | 0.371 | 12-Lipoxygenase inhibitor | 0.322 0.068 DBMET01451 | ||
| 0.33 | 0.009 | 0.33 | UDP-glucose 4-epimerase inhibitor | 0.185 0.02 DBMET01451 | ||
| 0.329 | 0.01 | 0.329 | Phospholipase A2 inhibitor | 0.153 0.071 DBMET01451 | ||
| 0.334 | 0.015 | 0.334 | Gastrin inhibitor | 0.221 0.117 DBMET01451 | ||
| 0.326 | 0.007 | 0.333 | Succinate dehydrogenase inhibitor | 0.333 0.007 DBMET01451 | DBMET01451 | |
| 0.332 | 0.014 | 0.332 | Protein-tyrosine phosphatase inhibitor | 0.303 0.018 DBMET01451 | ||
| 0.327 | 0.016 | 0.327 | Interferon gamma antagonist | 0.237 0.031 DBMET01451 | ||
| 0.319 | 0.009 | 0.319 | 5-Lipoxygenase inhibitor | 0.22 0.021 DBMET01451 | ||
| 0.323 | 0.019 | 0.323 | Mcl-1 antagonist | 0.207 0.052 DBMET01451 | ||
| 0.312 | 0.013 | 0.312 | Insulin sensitizer | 0.2 0.073 DBMET01451 | ||
| 0.301 | 0.005 | 0.301 | Triose-phosphate isomerase inhibitor | 0.173 0.015 DBMET01451 | ||
| 0.304 | 0.008 | 0.304 | Expectorant | 0.124 0.048 DBMET01451 | ||
| 0.334 | 0.038 | 0.334 | Vasodilator | |||
| 0.314 | 0.019 | 0.314 | Lipocortins synthesis antagonist | 0.234 0.039 DBMET01451 | ||
| 0.296 | 0.008 | 0.395 | Topoisomerase II alpha inhibitor | 0.395 0.005 DBMET01451 | DBMET01451 | |
| 0.312 | 0.03 | 0.312 | Platelet adhesion inhibitor | |||
| 0.314 | 0.035 | 0.4 | Peroxidase inhibitor | 0.4 0.02 DBMET01451 | DBMET01451 | |
| 0.283 | 0.005 | 0.506 | HIV-1 integrase (3'-Processing) inhibitor | 0.506 0.003 DBMET01451 | DBMET01451 | |
| 0.282 | 0.005 | 0.282 | HIV-1 integrase (Strand Transfer) inhibitor | 0.225 0.008 DBMET01451 | ||
| 0.282 | 0.01 | 0.282 | Cathepsin G inhibitor | |||
| 0.278 | 0.006 | 0.278 | Porphobilinogen synthase inhibitor | 0.234 0.009 DBMET01451 | ||
| 0.273 | 0.005 | 0.273 | Photosensitizer | 0.128 0.048 DBMET01451 | ||
| 0.282 | 0.014 | 0.282 | Cholesterol synthesis inhibitor | 0.204 0.026 DBMET01451 | ||
| 0.275 | 0.006 | 0.275 | Toll-Like receptor 2 antagonist | 0.179 0.034 DBMET01451 | ||
| 0.293 | 0.03 | 0.293 | Dual specificity phosphatase 3 inhibitor | 0.187 0.069 DBMET01451 | ||
| 0.306 | 0.05 | 0.306 | Antiamyloidogenic | |||
| 0.256 | 0.004 | 0.256 | Glutamate decarboxylase inhibitor | 0.198 0.007 DBMET01451 | ||
| 0.293 | 0.042 | 0.303 | Nitric oxide antagonist | 0.303 0.04 DBMET01451 | DBMET01451 | |
| 0.308 | 0.059 | 0.308 | Aryl hydrocarbon receptor agonist | |||
| 0.255 | 0.006 | 0.255 | Mucolytic | 0.132 0.044 DBMET01451 | ||
| 0.272 | 0.023 | 0.272 | Lipid peroxidase inhibitor | 0.157 0.064 DBMET01451 | ||
| 0.362 | 0.114 | 0.394 | Cyclophilin D inhibitor | 0.394 0.094 DBMET01451 | DBMET01451 | |
| 0.274 | 0.027 | 0.274 | Neurotrophic factor enhancer | 0.222 0.057 DBMET01451 | ||
| 0.285 | 0.041 | 0.285 | Tyrosine 3 hydroxylase inhibitor | 0.271 0.05 DBMET01451 | ||
| 0.29 | 0.05 | 0.29 | Pyruvate kinase inhibitor | 0.212 0.075 DBMET01451 | ||
| 0.252 | 0.013 | 0.252 | Ferrochelatase inhibitor | 0.129 0.048 DBMET01451 | ||
| 0.254 | 0.016 | 0.593 | Topoisomerase I inhibitor | 0.593 0.003 DBMET01451 | DBMET01451 | |
| 0.24 | 0.006 | 0.283 | Creatine kinase inhibitor | 0.283 0.004 DBMET01451 | DBMET01451 | |
| 0.241 | 0.008 | 0.241 | Uric acid excretion stimulant | 0.175 0.017 DBMET01451 | ||
| 0.234 | 0.002 | 0.234 | Ca2+-transporting ATPase inhibitor | 0.196 0.004 DBMET01451 | ||
| 0.236 | 0.009 | 0.236 | Arachidonic acid antagonist | 0.201 0.032 DBMET01451 | ||
| 0.266 | 0.039 | 0.284 | Hepatoprotectant | 0.284 0.034 DBMET01451 | DBMET01451 | |
| 0.243 | 0.017 | 0.243 | Alkylator | 0.115 0.073 DBMET01451 | ||
| 0.248 | 0.022 | 0.248 | Hemostatic | |||
| 0.241 | 0.017 | 0.241 | DNA intercalator | 0.154 0.041 DBMET01451 | ||
| 0.232 | 0.01 | 0.232 | Histidine decarboxylase inhibitor | 0.207 0.012 DBMET01451 | ||
| 0.239 | 0.019 | 0.239 | Protein-tyrosine phosphatase 1B inhibitor | 0.228 0.022 DBMET01451 | ||
| 0.234 | 0.014 | 0.234 | Antibacterial (Helicobacter pylori) | |||
| 0.26 | 0.046 | 0.26 | Anesthetic general | |||
| 0.217 | 0.004 | 0.217 | Topoisomerase II beta inhibitor | 0.101 0.009 DBMET01451 | ||
| 0.266 | 0.054 | 0.266 | Antimitotic | |||
| 0.236 | 0.024 | 0.236 | NADPH oxidase inhibitor | 0.142 0.06 DBMET01451 | ||
| 0.289 | 0.082 | 0.289 | Immunostimulant | 0.164 0.143 DBMET01451 | ||
| 0.335 | 0.129 | 0.372 | Calcium channel L-type activator | 0.372 0.101 DBMET01451 | DBMET01451 | |
| 0.225 | 0.02 | 0.225 | Chelator | 0.115 0.058 DBMET01451 | ||
| 0.224 | 0.02 | 0.224 | Mannose-6-phosphate isomerase inhibitor | 0.169 0.05 DBMET01451 | ||
| 0.235 | 0.033 | 0.235 | Amylase inhibitor | 0.175 0.053 DBMET01451 | ||
| 0.214 | 0.012 | 0.214 | Potassium channel (Ca-activated) activator | 0.101 0.055 DBMET01451 | ||
| 0.228 | 0.028 | 0.228 | Cytokine production inhibitor | |||
| 0.276 | 0.08 | 0.276 | Spasmolytic | |||
| 0.259 | 0.063 | 0.259 | Hypolipemic | |||
| 0.201 | 0.006 | 0.201 | DOPA decarboxylase inhibitor | 0.189 0.008 DBMET01451 | ||
| 0.262 | 0.067 | 0.262 | Platelet antagonist | 0.227 0.084 DBMET01451 | ||
| 0.199 | 0.004 | 0.199 | Xanthine dehydrogenase inhibitor | 0.116 0.012 DBMET01451 | ||
| 0.198 | 0.005 | 0.198 | CDC25B inhibitor | 0.132 0.009 DBMET01451 | ||
| 0.233 | 0.04 | 0.233 | Amyloid beta precursor protein antagonist | |||
| 0.202 | 0.01 | 0.202 | TRPA1 agonist | 0.155 0.027 DBMET01451 | ||
| 0.205 | 0.013 | 0.205 | Carbonic anhydrase XIII inhibitor | 0.065 0.063 DBMET01451 | ||
| 0.201 | 0.014 | 0.278 | Telomerase inhibitor | 0.278 0.007 DBMET01451 | DBMET01451 | |
| 0.195 | 0.008 | 0.195 | Macrophage migration inhibitory factor inhibitor | 0.07 0.066 DBMET01451 | ||
| 0.222 | 0.038 | 0.222 | Heat shock protein 90 alpha antagonist | 0.131 0.11 DBMET01451 | ||
| 0.199 | 0.015 | 0.199 | Catalase inhibitor | |||
| 0.203 | 0.02 | 0.224 | GABA C receptor agonist | 0.224 0.017 DBMET01451 | DBMET01451 | |
| 0.203 | 0.02 | 0.491 | Antineoplastic antibiotic | 0.491 0.004 DBMET01451 | DBMET01451 | |
| 0.197 | 0.016 | 0.197 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.172 0.021 DBMET01451 | ||
| 0.201 | 0.021 | 0.201 | CF transmembrane conductance regulator agonist | |||
| 0.2 | 0.02 | 0.2 | Microtubule formation inhibitor | 0.125 0.055 DBMET01451 | ||
| 0.202 | 0.022 | 0.202 | Interleukin 4 antagonist | 0.139 0.06 DBMET01451 | ||
| 0.19 | 0.01 | 0.19 | ABCA1 expression enhancer | 0.088 0.069 DBMET01451 | ||
| 0.184 | 0.005 | 0.24 | GABA aminotransferase inhibitor | 0.24 0.004 DBMET01451 | DBMET01451 | |
| 0.238 | 0.062 | 0.238 | Amyloid beta aggregation inhibitor | 0.151 0.107 DBMET01451 | ||
| 0.181 | 0.006 | 0.181 | Ornithine decarboxylase inhibitor | 0.148 0.012 DBMET01451 | ||
| 0.199 | 0.029 | 0.199 | GABA C receptor rho-2 antagonist | 0.162 0.058 DBMET01451 | ||
| 0.206 | 0.04 | 0.206 | Phospholipase C inhibitor | 0.192 0.049 DBMET01451 | ||
| 0.199 | 0.035 | 0.199 | Cyclooxygenase 1 inhibitor | |||
| 0.173 | 0.009 | 0.173 | CDC25A inhibitor | 0.16 0.011 DBMET01451 | ||
| 0.197 | 0.034 | 0.197 | Catenin beta inhibitor | 0.17 0.067 DBMET01451 | ||
| 0.176 | 0.012 | 0.176 | Glutamate dehydrogenase inhibitor | 0.152 0.015 DBMET01451 | ||
| 0.183 | 0.022 | 0.183 | Carbonic anhydrase XV inhibitor | 0.156 0.029 DBMET01451 | ||
| 0.208 | 0.047 | 0.208 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.22 | 0.06 | 0.22 | Nitric-oxide synthase stimulant | 0.172 0.148 DBMET01451 | ||
| 0.175 | 0.016 | 0.175 | AMP-activated protein kinase stimulant | 0.152 0.027 DBMET01451 | ||
| 0.181 | 0.023 | 0.181 | Sphingosine 1-phosphate receptor 5 antagonist | 0.122 0.121 DBMET01451 | ||
| 0.177 | 0.02 | 0.177 | Carbonic anhydrase III inhibitor | 0.162 0.024 DBMET01451 | ||
| 0.191 | 0.034 | 0.191 | Cell wall synthesis inhibitor | 0.115 0.108 DBMET01451 | ||
| 0.168 | 0.012 | 0.168 | Thioredoxin inhibitor | 0.105 0.043 DBMET01451 | ||
| 0.196 | 0.041 | 0.196 | ATPase inhibitor | 0.148 0.106 DBMET01451 | ||
| 0.174 | 0.019 | 0.174 | Adenylate kinase inhibitor | 0.139 0.031 DBMET01451 | ||
| 0.19 | 0.037 | 0.19 | Interleukin 1 antagonist | |||
| 0.166 | 0.015 | 0.166 | GABA C receptor rho-1 antagonist | 0.125 0.036 DBMET01451 | ||
| 0.157 | 0.008 | 0.157 | Leukotriene synthesis inhibitor | |||
| 0.167 | 0.019 | 0.167 | DNA repair enzyme inhibitor | |||
| 0.151 | 0.005 | 0.151 | Leukocyte elastase inhibitor | |||
| 0.167 | 0.021 | 0.167 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.082 DBMET01451 | ||
| 0.165 | 0.02 | 0.19 | HIV-1 integrase (Overall Integration) inhibitor | 0.19 0.014 DBMET01451 | DBMET01451 | |
| 0.176 | 0.031 | 0.176 | Adenylate cyclase inhibitor | 0.093 0.091 DBMET01451 | ||
| 0.151 | 0.006 | 0.151 | Elastase 1 inhibitor | |||
| 0.163 | 0.018 | 0.163 | Carbonic anhydrase VI inhibitor | 0.108 0.035 DBMET01451 | ||
| 0.146 | 0.003 | 0.146 | Retinoid X alpha receptor agonist | 0.061 0.011 DBMET01451 | ||
| 0.244 | 0.102 | 0.244 | Insulysin inhibitor | 0.207 0.147 DBMET01451 | ||
| 0.154 | 0.017 | 0.154 | NADH dehydrogenase inhibitor | 0.14 0.02 DBMET01451 | ||
| 0.167 | 0.03 | 0.167 | Interleukin 1b antagonist | |||
| 0.196 | 0.063 | 0.196 | Sigma receptor agonist | 0.141 0.092 DBMET01451 | ||
| 0.179 | 0.048 | 0.179 | Insulin secretagoues | 0.128 0.1 DBMET01451 | ||
| 0.18 | 0.049 | 0.18 | Heat shock protein 90 antagonist | |||
| 0.177 | 0.046 | 0.177 | Tubulin antagonist | 0.14 0.063 DBMET01451 | ||
| 0.137 | 0.009 | 0.158 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.158 0.006 DBMET01451 | DBMET01451 | |
| 0.139 | 0.012 | 0.139 | Thioredoxin reductase inhibitor | 0.097 0.031 DBMET01451 | ||
| 0.146 | 0.02 | 0.151 | Anabolic | 0.151 0.017 DBMET01451 | DBMET01451 | |
| 0.165 | 0.041 | 0.165 | Adenylate cyclase stimulant | 0.139 0.083 DBMET01451 | ||
| 0.152 | 0.029 | 0.152 | GABA C receptor antagonist | 0.14 0.036 DBMET01451 | ||
| 0.162 | 0.04 | 0.162 | Farnesoid X receptor antagonist | 0.125 0.092 DBMET01451 | ||
| 0.134 | 0.013 | 0.134 | Potassium channel large-conductance Ca-activated activator | 0.068 0.047 DBMET01451 | ||
| 0.123 | 0.005 | 0.123 | Aconitate hydratase inhibitor | 0.103 0.008 DBMET01451 | ||
| 0.13 | 0.013 | 0.13 | Leukotriene antagonist | 0.062 0.048 DBMET01451 | ||
| 0.147 | 0.03 | 0.147 | Caspase 3 inhibitor | |||
| 0.207 | 0.091 | 0.294 | Angiogenesis stimulant | 0.294 0.051 DBMET01451 | DBMET01451 | |
| 0.14 | 0.024 | 0.14 | Electrolyte absorption antagonist | 0.093 0.068 DBMET01451 | ||
| 0.124 | 0.009 | 0.124 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.157 | 0.042 | 0.346 | Cell adhesion inhibitor | 0.346 0.007 DBMET01451 | DBMET01451 | |
| 0.17 | 0.057 | 0.17 | Cyclooxygenase inhibitor | |||
| 0.126 | 0.013 | 0.201 | HIV-1 integrase inhibitor | 0.201 0.005 DBMET01451 | DBMET01451 | |
| 0.163 | 0.051 | 0.163 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.157 0.06 DBMET01451 | ||
| 0.127 | 0.016 | 0.127 | Phenylalanine 4-hydroxylase inhibitor | 0.123 0.017 DBMET01451 | ||
| 0.115 | 0.004 | 0.115 | Retinoid X receptor agonist | 0.07 0.01 DBMET01451 | ||
| 0.151 | 0.043 | 0.153 | Heat shock protein 70 antagonist | 0.153 0.04 DBMET01451 | DBMET01451 | |
| 0.122 | 0.015 | 0.122 | Argininosuccinate synthase inhibitor | 0.081 0.025 DBMET01451 | ||
| 0.125 | 0.021 | 0.125 | Interleukin 5 antagonist | |||
| 0.201 | 0.097 | 0.201 | Peptidyltransferase inhibitor | 0.199 0.1 DBMET01451 | ||
| 0.116 | 0.012 | 0.116 | Purinergic P2X1 antagonist | 0.103 0.016 DBMET01451 | ||
| 0.111 | 0.008 | 0.111 | CD45 antagonist | 0.059 0.023 DBMET01451 | ||
| 0.146 | 0.044 | 0.146 | Protein kinase (CK2) alpha inhibitor | |||
| 0.157 | 0.056 | 0.157 | Alkaline phosphatase inhibitor | |||
| 0.113 | 0.013 | 0.113 | Estrogen-related receptor beta agonist | 0.085 0.053 DBMET01451 | ||
| 0.111 | 0.013 | 0.111 | Prostaglandin E2 antagonist | |||
| 0.133 | 0.035 | 0.133 | Beta glucuronidase inhibitor | 0.124 0.042 DBMET01451 | ||
| 0.102 | 0.004 | 0.102 | Retinoic acid alpha receptor agonist | 0.066 0.007 DBMET01451 | ||
| 0.111 | 0.014 | 0.111 | Neuraminidase (influenza) inhibitor | 0.074 0.03 DBMET01451 | ||
| 0.112 | 0.015 | 0.112 | Biliverdin reductase inhibitor | 0.074 0.03 DBMET01451 | ||
| 0.105 | 0.01 | 0.105 | Fatty acid synthase inhibitor | 0.054 0.045 DBMET01451 | ||
| 0.115 | 0.02 | 0.115 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.152 | 0.057 | 0.152 | Bone formation stimulant | |||
| 0.116 | 0.021 | 0.116 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.134 | 0.04 | 0.134 | Protein kinase (CK2) inhibitor | 0.085 0.077 DBMET01451 | ||
| 0.208 | 0.115 | 0.208 | 5 Hydroxytryptamine release stimulant | |||
| 0.168 | 0.075 | 0.168 | Antipruritic | |||
| 0.094 | 0.004 | 0.094 | Pregnane X receptor antagonist | 0.068 0.016 DBMET01451 | ||
| 0.125 | 0.035 | 0.13 | Prolactin inhibitor | 0.13 0.032 DBMET01451 | DBMET01451 | |
| 0.106 | 0.017 | 0.106 | Prostaglandin EP2 antagonist | |||
| 0.099 | 0.011 | 0.099 | Leukotriene B4 antagonist | 0.056 0.033 DBMET01451 | ||
| 0.141 | 0.053 | 0.141 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.114 | 0.026 | 0.114 | Bile acid receptor antagonist | 0.106 0.038 DBMET01451 | ||
| 0.102 | 0.015 | 0.102 | NMDA receptor glycine site agonist | |||
| 0.095 | 0.011 | 0.095 | Nitric oxide donor | |||
| 0.138 | 0.055 | 0.138 | Anesthetic local | |||
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | 0.09 0.016 DBMET01451 | ||
| 0.1 | 0.017 | 0.1 | Prostaglandin antagonist | |||
| 0.145 | 0.063 | 0.153 | Neurotrophic factor | 0.153 0.056 DBMET01451 | DBMET01451 | |
| 0.107 | 0.025 | 0.107 | Carbonic anhydrase V inhibitor | |||
| 0.105 | 0.023 | 0.105 | Carbonic anhydrase VA inhibitor | |||
| 0.101 | 0.02 | 0.103 | Glycine receptor agonist | 0.103 0.019 DBMET01451 | DBMET01451 | |
| 0.18 | 0.099 | 0.18 | Histone acetyltransferase inhibitor | |||
| 0.126 | 0.045 | 0.139 | Estrogen antagonist | 0.139 0.029 DBMET01451 | DBMET01451 | |
| 0.135 | 0.055 | 0.135 | CC chemokine 6 receptor antagonist | 0.127 0.084 DBMET01451 | ||
| 0.119 | 0.04 | 0.119 | Breast cancer-resistant protein inhibitor | |||
| 0.095 | 0.017 | 0.169 | Neuraminidase inhibitor | 0.169 0.005 DBMET01451 | DBMET01451 | |
| 0.163 | 0.085 | 0.163 | Tumour necrosis factor antagonist | |||
| 0.126 | 0.049 | 0.126 | Aminopeptidase B inhibitor | 0.104 0.062 DBMET01451 | ||
| 0.08 | 0.004 | 0.08 | Retinoic acid receptor agonist | 0.035 0.008 DBMET01451 | ||
| 0.085 | 0.009 | 0.085 | DNA helicase inhibitor | 0.055 0.036 DBMET01451 | ||
| 0.113 | 0.039 | 0.113 | Calcium antagonist | |||
| 0.101 | 0.028 | 0.111 | D-Ala-D-Ala ligase inhibitor | 0.111 0.019 DBMET01451 | DBMET01451 | |
| 0.107 | 0.033 | 0.107 | Glutamate release inhibitor | 0.086 0.072 DBMET01451 | ||
| 0.094 | 0.021 | 0.094 | NMDA receptor agonist | |||
| 0.114 | 0.041 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.102 | 0.031 | 0.102 | Phosphofructokinase-1 inhibitor | 0.094 0.034 DBMET01451 | ||
| 0.098 | 0.028 | 0.098 | Estrogen receptor alpha antagonist | 0.09 0.035 DBMET01451 | ||
| 0.148 | 0.079 | 0.148 | Diuretic | |||
| 0.171 | 0.103 | 0.171 | Interleukin antagonist | |||
| 0.15 | 0.082 | 0.19 | Thrombolytic | 0.19 0.057 DBMET01451 | DBMET01451 | |
| 0.093 | 0.024 | 0.093 | Beta tubulin antagonist | 0.051 0.046 DBMET01451 | ||
| 0.088 | 0.021 | 0.088 | Aldose reductase inhibitor | |||
| 0.085 | 0.018 | 0.085 | Heat shock protein 90 beta antagonist | |||
| 0.098 | 0.031 | 0.098 | Interferon agonist | 0.071 0.069 DBMET01451 | ||
| 0.145 | 0.078 | 0.153 | NOS3 expression enhancer | 0.153 0.069 DBMET01451 | DBMET01451 | |
| 0.079 | 0.012 | 0.081 | 5-Alpha-reductase inhibitor | 0.081 0.012 DBMET01451 | DBMET01451 | |
| 0.109 | 0.042 | 0.109 | Antineoplastic alkaloid | |||
| 0.074 | 0.009 | 0.074 | Factor III inhibitor | 0.05 0.034 DBMET01451 | ||
| 0.075 | 0.011 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 DBMET01451 | DBMET01451 | |
| 0.073 | 0.009 | 0.073 | Urate transporter 1 inhibitor | |||
| 0.072 | 0.008 | 0.072 | Nicotinic acid receptor agonist | 0.036 0.025 DBMET01451 | ||
| 0.1 | 0.037 | 0.1 | Glutathione S-transferase inhibitor | |||
| 0.071 | 0.011 | 0.071 | Heparanase inhibitor | |||
| 0.071 | 0.011 | 0.071 | Dihydroorotase inhibitor | 0.043 0.033 DBMET01451 | ||
| 0.12 | 0.061 | 0.12 | Transcription factor STAT6 inhibitor | |||
| 0.081 | 0.022 | 0.081 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 DBMET01451 | ||
| 0.066 | 0.008 | 0.066 | Prostaglandin agonist | 0.035 0.017 DBMET01451 | ||
| 0.092 | 0.034 | 0.092 | T cell inhibitor | |||
| 0.063 | 0.005 | 0.063 | Retinoid X receptor antagonist | 0.053 0.01 DBMET01451 | ||
| 0.082 | 0.025 | 0.082 | Glutamate (mGluR7) antagonist | 0.068 0.046 DBMET01451 | ||
| 0.081 | 0.024 | 0.081 | Exportin-1 inhibitor | |||
| 0.09 | 0.034 | 0.09 | Aminopeptidase I inhibitor | 0.078 0.044 DBMET01451 | ||
| 0.128 | 0.072 | 0.128 | Cyclooxygenase 2 inhibitor | |||
| 0.089 | 0.034 | 0.089 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.086 | 0.031 | 0.087 | GABA B receptor agonist | 0.087 0.03 DBMET01451 | DBMET01451 | |
| 0.127 | 0.073 | 0.129 | Vanilloid 1 agonist | 0.129 0.068 DBMET01451 | DBMET01451 | |
| 0.064 | 0.01 | 0.064 | Nicotinic acid receptor 2 agonist | 0.043 0.018 DBMET01451 | ||
| 0.096 | 0.043 | 0.121 | Transcription factor NF kappa B stimulant | 0.121 0.025 DBMET01451 | DBMET01451 | |
| 0.077 | 0.024 | 0.077 | Transcription factor AP-1 inhibitor | |||
| 0.058 | 0.005 | 0.058 | ATP citrate lysase inhibitor | 0.052 0.007 DBMET01451 | ||
| 0.056 | 0.004 | 0.056 | Elastase 3A inhibitor | |||
| 0.056 | 0.004 | 0.056 | Elastase 2B inhibitor | |||
| 0.056 | 0.004 | 0.056 | Elastase 3B inhibitor | |||
| 0.072 | 0.021 | 0.072 | Elastase inhibitor | |||
| 0.119 | 0.069 | 0.19 | DNA polymerase I inhibitor | 0.19 0.031 DBMET01451 | DBMET01451 | |
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | |||
| 0.062 | 0.013 | 0.062 | Glutamate (mGluR4) antagonist | |||
| 0.067 | 0.017 | 0.067 | Potassium channel Kv1.3 blocker | |||
| 0.053 | 0.004 | 0.053 | Retinoic acid beta receptor agonist | 0.027 0.007 DBMET01451 | ||
| 0.073 | 0.024 | 0.073 | Thromboxane antagonist | |||
| 0.052 | 0.005 | 0.052 | Retinoid X alpha receptor antagonist | 0.039 0.016 DBMET01451 | ||
| 0.06 | 0.013 | 0.06 | Glutamate (mGluR group III) antagonist | |||
| 0.06 | 0.013 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET01451 | ||
| 0.157 | 0.11 | 0.157 | Psychostimulant | |||
| 0.059 | 0.012 | 0.059 | Dopamine D5 agonist | 0.046 0.021 DBMET01451 | ||
| 0.059 | 0.012 | 0.059 | Guanylate cyclase inhibitor | 0.04 0.034 DBMET01451 | ||
| 0.076 | 0.03 | 0.076 | Aromatase inhibitor | 0.061 0.041 DBMET01451 | ||
| 0.104 | 0.058 | 0.128 | Estrogen receptor beta antagonist | 0.128 0.024 DBMET01451 | DBMET01451 | |
| 0.187 | 0.141 | 0.338 | Streptokinase A inhibitor | 0.338 0.065 DBMET01451 | DBMET01451 | |
| 0.064 | 0.019 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.049 | 0.005 | 0.049 | Retinoid X beta receptor agonist | 0.021 0.014 DBMET01451 | ||
| 0.094 | 0.049 | 0.094 | ATPase (Vacuolar H+) inhibitor | |||
| 0.049 | 0.005 | 0.049 | Retinoid X gamma receptor agonist | 0.022 0.017 DBMET01451 | ||
| 0.134 | 0.09 | 0.134 | Thiol protease inhibitor | |||
| 0.088 | 0.045 | 0.27 | Cell adhesion molecule inhibitor | 0.27 0.005 DBMET01451 | DBMET01451 | |
| 0.065 | 0.022 | 0.065 | Carbonic anhydrase XIV inhibitor | |||
| 0.067 | 0.024 | 0.106 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.106 0.009 DBMET01451 | DBMET01451 | |
| 0.074 | 0.032 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.054 | 0.011 | 0.061 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.061 0.007 DBMET01451 | DBMET01451 | |
| 0.058 | 0.016 | 0.058 | Microtubule stabilization | |||
| 0.066 | 0.025 | 0.066 | Bcl-xL inhibitor | |||
| 0.062 | 0.021 | 0.062 | Glucose-6-phosphate translocase inhibitor | |||
| 0.065 | 0.025 | 0.065 | Thromboxane A2 antagonist | |||
| 0.069 | 0.029 | 0.069 | Carbonic anhydrase VB inhibitor | |||
| 0.048 | 0.008 | 0.048 | Cholesterol ester transfer protein antagonist | |||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | 0.054 0.047 DBMET01451 | ||
| 0.046 | 0.006 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 DBMET01451 | ||
| 0.064 | 0.025 | 0.064 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.063 | 0.025 | 0.063 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.062 | 0.026 | 0.068 | Dihydroorotate oxidase inhibitor | 0.068 0.019 DBMET01451 | DBMET01451 | |
| 0.067 | 0.03 | 0.067 | Maillard reaction inhibitor | |||
| 0.07 | 0.035 | 0.07 | Interferon inducer | |||
| 0.039 | 0.004 | 0.039 | Retinoic acid alpha receptor antagonist | 0.034 0.005 DBMET01451 | ||
| 0.039 | 0.004 | 0.039 | Retinoic acid receptor antagonist | 0.029 0.006 DBMET01451 | ||
| 0.235 | 0.201 | 0.235 | DNA directed DNA polymerase inhibitor | |||
| 0.038 | 0.004 | 0.038 | Retinoic acid gamma receptor agonist | 0.029 0.007 DBMET01451 | ||
| 0.037 | 0.005 | 0.04 | Vanilloid 2 agonist | 0.04 0.004 DBMET01451 | DBMET01451 | |
| 0.035 | 0.003 | 0.035 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET01451 | ||
| 0.145 | 0.114 | 0.145 | Neurotensin receptor agonist | |||
| 0.043 | 0.013 | 0.043 | Free fatty acid receptor 1 antagonist | |||
| 0.041 | 0.011 | 0.041 | Purinergic P2Y14 antagonist | 0.03 0.02 DBMET01451 | ||
| 0.229 | 0.2 | 0.229 | Alpha-glucosidase inhibitor | |||
| 0.038 | 0.009 | 0.038 | Prostaglandin EP2 agonist | |||
| 0.047 | 0.018 | 0.047 | GABA uptake inhibitor | 0.037 0.031 DBMET01451 | ||
| 0.046 | 0.018 | 0.046 | Farnesoid X receptor agonist | |||
| 0.035 | 0.007 | 0.035 | Retinoid X gamma receptor antagonist | 0.028 0.017 DBMET01451 | ||
| 0.044 | 0.017 | 0.047 | Glutamate (mGluR8) agonist | 0.047 0.014 DBMET01451 | DBMET01451 | |
| 0.103 | 0.076 | 0.194 | Electron transport complex I inhibitor | 0.194 0.009 DBMET01451 | DBMET01451 | |
| 0.038 | 0.011 | 0.038 | NMDA 2D receptor antagonist | 0.03 0.016 DBMET01451 | ||
| 0.045 | 0.018 | 0.045 | Arginase inhibitor | |||
| 0.033 | 0.007 | 0.033 | Prostaglandin EP4 agonist | |||
| 0.037 | 0.012 | 0.037 | Prostaglandin EP4 antagonist | |||
| 0.06 | 0.035 | 0.06 | Lipocortins synthesis agonist | |||
| 0.056 | 0.031 | 0.056 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.073 | 0.048 | 0.073 | Calcium channel L-type blocker | |||
| 0.029 | 0.005 | 0.029 | Retinoid X beta receptor antagonist | 0.019 0.018 DBMET01451 | ||
| 0.164 | 0.14 | 0.164 | Tumour necrosis factor alpha release inhibitor | |||
| 0.048 | 0.025 | 0.048 | Estradiol 17 beta-dehydrogenase inhibitor | 0.045 0.028 DBMET01451 | ||
| 0.056 | 0.034 | 0.056 | Thromboxane synthase inhibitor | |||
| 0.041 | 0.018 | 0.041 | Somatostatin 5 antagonist | |||
| 0.032 | 0.01 | 0.032 | Prostaglandin E2 agonist | |||
| 0.031 | 0.01 | 0.031 | Prostaglandin EP1 antagonist | |||
| 0.044 | 0.023 | 0.044 | Kainate receptor agonist | |||
| 0.129 | 0.109 | 0.129 | Growth hormone agonist | |||
| 0.038 | 0.018 | 0.038 | Purinergic P2Y2 antagonist | |||
| 0.031 | 0.011 | 0.031 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.039 | 0.02 | 0.039 | Fumarate hydratase inhibitor | |||
| 0.044 | 0.026 | 0.044 | Angiotensin AT1 receptor antagonist | |||
| 0.028 | 0.01 | 0.028 | Leukotriene B4 receptor 2 antagonist | 0.024 0.014 DBMET01451 | ||
| 0.096 | 0.078 | 0.096 | Toll-Like receptor 4 antagonist | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 DBMET01451 | ||
| 0.066 | 0.05 | 0.066 | MDM2 inhibitor | |||
| 0.026 | 0.009 | 0.026 | 5-Alpha-reductase 1 inhibitor | |||
| 0.021 | 0.004 | 0.021 | Retinoic acid beta receptor antagonist | 0.018 0.005 DBMET01451 | ||
| 0.08 | 0.064 | 0.08 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.076 | 0.06 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.045 DBMET01451 | DBMET01451 | |
| 0.04 | 0.024 | 0.04 | Leukotriene C4 antagonist | |||
| 0.02 | 0.004 | 0.02 | Retinoic acid receptor gamma antagonist | 0.015 0.005 DBMET01451 | ||
| 0.063 | 0.047 | 0.063 | Selectin antagonist | |||
| 0.13 | 0.115 | 0.172 | MAP kinase kinase 4 inhibitor | 0.172 0.03 DBMET01451 | DBMET01451 | |
| 0.05 | 0.036 | 0.05 | Estrogen agonist | 0.047 0.037 DBMET01451 | ||
| 0.031 | 0.017 | 0.031 | Leukotriene B4 receptor 1 antagonist | |||
| 0.019 | 0.005 | 0.024 | Antibiotic Tetracycline-like | 0.024 0.003 DBMET01451 | DBMET01451 | |
| 0.063 | 0.05 | 0.063 | Beta adrenoreceptor antagonist | |||
| 0.058 | 0.045 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.058 | 0.046 | 0.058 | TRPA1 antagonist | |||
| 0.037 | 0.025 | 0.037 | Glutamate (mGluR3) antagonist | 0.034 0.029 DBMET01451 | ||
| 0.048 | 0.035 | 0.048 | Plasminogen activator inhibitor antagonist | |||
| 0.096 | 0.084 | 0.096 | Protein kinase C gamma inhibitor | |||
| 0.034 | 0.023 | 0.034 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.221 | 0.21 | 0.221 | DNA polymerase beta inhibitor | |||
| 0.036 | 0.025 | 0.036 | Glutamate (mGluR8) antagonist | 0.034 0.028 DBMET01451 | ||
| 0.05 | 0.04 | 0.05 | Alpha tubulin antagonist | 0.048 0.044 DBMET01451 | ||
| 0.022 | 0.012 | 0.025 | 5-Alpha-reductase 2 inhibitor | 0.025 0.01 DBMET01451 | DBMET01451 | |
| 0.023 | 0.014 | 0.023 | Elastase 2 inhibitor | |||
| 0.023 | 0.014 | 0.023 | Elastase 2A inhibitor | |||
| 0.05 | 0.041 | 0.05 | Autotaxin inhibitor | |||
| 0.044 | 0.035 | 0.044 | Carbonic anhydrase VII inhibitor | |||
| 0.028 | 0.019 | 0.028 | Uridine phosphorylase inhibitor | |||
| 0.032 | 0.024 | 0.032 | Catechol O-methyltransferase inhibitor | |||
| 0.026 | 0.018 | 0.026 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.037 | 0.03 | 0.037 | Vanilloid 3 antagonist | |||
| 0.048 | 0.041 | 0.048 | Ornithine carbamoyltransferase inhibitor | |||
| 0.033 | 0.026 | 0.033 | Protein kinase C beta I inhibitor | |||
| 0.179 | 0.173 | 0.179 | Prostaglandin dehydrogenase inhibitor | |||
| 0.024 | 0.017 | 0.062 | Protein 30S ribosomal subunit inhibitor | 0.062 0.006 DBMET01451 | DBMET01451 | |
| 0.045 | 0.039 | 0.045 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Angiotensin II receptor antagonist | |||
| 0.032 | 0.027 | 0.032 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.038 | 0.033 | 0.038 | Liver X receptor alpha agonist | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.024 | 0.022 | 0.024 | Calcium-sensing receptor agonist | |||
| 0.02 | 0.018 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.025 | 0.024 | 0.025 | Liver X receptor beta antagonist | |||
| 0.012 | 0.011 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.056 | 0.055 | 0.056 | Purinergic P2X2 antagonist | |||
| 0.195 | 0.198 | 0.199 | Interleukin 2 agonist | 0.199 0.192 DBMET01451 | DBMET01451 | |
| 0.063 | 0.067 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET01451 | DBMET01451 | |
| 0.076 | 0.085 | 0.124 | Vanilloid agonist | 0.124 0.016 DBMET01451 | DBMET01451 | |
| 0.055 | 0.065 | 0.072 | Heme oxygenase stimulant | 0.072 0.023 DBMET01451 | DBMET01451 | |
| 0.028 | 0.04 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.023 DBMET01451 | DBMET01451 | |
| 0.012 | 0.027 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.02 0.009 DBMET01451 | DBMET01451 | |
| 0.053 | 0.082 | 0.068 | Protein kinase C beta inhibitor | 0.068 0.052 DBMET01451 | DBMET01451 | |
| 0.008 | 0.062 | 0.033 | Estrogen receptor beta agonist | 0.033 0.023 DBMET01451 | DBMET01451 | |
| 0.075 | 0.152 | 0.172 | Acetylcholinesterase inhibitor | 0.172 0.043 DBMET01451 | DBMET01451 | |
| 0.047 | 0.175 | 0.113 | M18 aspartyl aminopeptidase inhibitor | 0.113 0.077 DBMET01451 | DBMET01451 | |
| 0.045 | 0.184 | 0.083 | Protein kinase C delta inhibitor | 0.083 0.072 DBMET01451 | DBMET01451 | |
| 0.048 | 0.308 | 0.122 | Anticoagulant | 0.122 0.11 DBMET01451 | DBMET01451 | |
| 0.047 | 0.316 | 0.129 | Cholinergic | 0.129 0.097 DBMET01451 | DBMET01451 | |
| 0.03 | 0.508 | 0.059 | Prolactin release inhibitor | 0.059 0.056 DBMET01451 | DBMET01451 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |